Further publication on CAMI1 study in Nephro-News
01.06.2019
The first data acquired within the CAMI1 study were again described and published within the magazine NephroNews.
01.06.2019
The first data acquired within the CAMI1 study were again described and published within the magazine NephroNews.
27.04.2019
Das Poster “Selective CRP apheresis as a new treatment option in STEMI: Final results of the CAMI1 Study” von der CAMI1-Studiengruppe wurde als Highlight der DGK Jahrestagung im Bereich “Interventionelle Kardiologie” vorgestellt.
29.03.2019
First data on the treatment of myocardial infarction patients were published in the journal Therapeutic Apheresis and Dialysis.
25.07.2018
The abstract "Selective CRP apheresis as a new therapeutic option in the treatment of acute myocardial infarction (STEMI)" by Dr. Wolfgang Ries was awarded as one of the 10 best at the 10th Annual Meeting of the German Society for Nephrology (DGfN) 2018.
07.04.2018
The poster "Selective CRP apheresis as a new treatment option in acute myocardial infarction (CAMI1 study)" by Prof. Dr. Christoph Garlichs was awarded a poster prize at the 84th Annual Meeting of the DGK.
06.11.2018
The article describes for the first time the treatment of a patient after an acute myocardial infarction (STEMI) with the PentraSorb® CRP. The patient was treated twice with immunapheresis and tolerated the treatment without side effects. The CRP concentration could be reduced by approx. 45%.